|
The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder CancerThis activity is intended for hematologists, medical oncologists, urologists and other healthcare providers involved in the treatment of urothelial bladder carcinoma. Once registered, you will receive an email with specific instructions including a link to use on the day of the event to log in and view the webinar. A link will be provided for access to a CME credit form within 5 days after the meeting. SUBMIT CHALLENGING CASES AND QUESTIONS |